electroCore to Participate at H.C. Wainwright Global Investment Conference
Rhea-AI Summary
electroCore (NASDAQ:ECOR), a bioelectronic medicine and wellness company, announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference. The event will be held on September 9, 2025, at the Lotte New York Palace Hotel in New York.
The company's management team will be available for one-on-one meetings throughout the conference day. Interested investors can schedule meetings through their H.C. Wainwright sales representative or by contacting electroCore's Investor Relations directly.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ECOR declined 0.94%, reflecting a mild negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $363K from the company's valuation, bringing the market cap to $38M at that time.
Data tracked by StockTitan Argus on the day of publication.
ROCKAWAY, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the H.C. Wainwright 27th Annual Global Investment Conference. The conference will take place in New York on Tuesday, September 9, 2025 at the Lotte New York Palace Hotel. Management will host one-on-one meetings throughout the day.
Investors who wish to request a meeting should contact their sales representative at H.C. Wainwright or reach out to electroCore Investor Relations at ecor@fnkir.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) presenting at the H.C. Wainwright Conference?
How can investors schedule meetings with electroCore management at the H.C. Wainwright Conference?
Where will the H.C. Wainwright Global Investment Conference with electroCore take place?
What type of meetings will electroCore management host at the H.C. Wainwright Conference?
